Chinese pharmaceutical dealers CEO of Kangshino Biology Yuxuefeng /Span> /Span> messenger ribonucleic acid (mRNA) NotThe disease vaccine is comparable to Modna (Modna) < < < < < < < < < < < < < < < <Span> and Pfizer- biontech ( > Pfizer-Biontech) vaccine.Not According to Reuters, > Yu Xuefeng Span> Friday (February 3) Modna and Pfizer- biontech Vaccine is not approved in China, so it cannot be used Span> vaccine, but according to the published data, he believes that he believesNotNuo The products are as good as the launching MRNA vaccine.Not Kangshino issued an announcement on January 5 that the first MRNA vaccine CS-2034 has entered the trial production stage, and in a clinical study that enhances safety and immunogenicity, it has obtainedPositive staged data.Not For the Chinese government's strong willingness to develop domestic MRNA vaccines, Yuxuefeng There are currently not many public information about this, but from a technical point of view, any product only meets the regulatory requirements of regulatory requirementsThere is no reason not to let them enter the market.Not Yu Xue > said, SPAN> Kangshino It is currently discussing with the Chinese regulatory agency on the later research schemes of CS-2034 and will be tested this year.Not He also said that if the vaccine is approved, the company will find a way to reduce the cost of manufacturing and deployment of the MRNA vaccine.Not He pointed out that compared with Pfizer's hopes to sell about $ 120 (about S $ 158.83) in the United States this year, Span> vaccine will definitely be cheaper.Not After China relaxed the crown disease prevention restrictions in December last year, it has not yet approved the use of foreign MRNA vaccines and has not approved domestic vaccines with the technology.Not It is understood that MRNA technology is more plastic and easier to adjust to solve new variants than traditional vaccine methods, but MRNA vaccines usually need more expensive super cold storage storage.At present, researchers have made some progress in ensuring stability at higher temperatures.